A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%

The True Post icon

The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach to treating the cancer.

Source: TIME

TAGGED:
Share This Article
The newsroom of The True Post.
Leave a Comment